Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219969 · ClinicalTrials.gov registry record · NA
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04219969: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT04219969 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04219969, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To compare the results and understand the possible benefits from FDG-PET/MRI during different scanning time points after FDG, a type of contrast drug, is given.
Primary Outcome
Identifying the specific malignancy
Interventions
- PROCEDURE Positron Emission Tomography
- DEVICE Magnetic Resonance Imaging
- DRUG Fludeoxyglucose F-18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
What the finished NCT04219969 record still lists
NCT04219969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Positron Emission Tomography is the first listed.
NCT04219969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04219969 about?
NCT04219969 is a clinical study titled "FDG PET-MRI for the Diagnosis of Spinal Cord Lesions". To compare the results and understand the possible benefits from FDG-PET/MRI during different scanning time points after FDG, a type of contrast drug, is given.
What is the current status of trial NCT04219969?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-09-21. Estimated completion is 2024-05-07.
What interventions are being tested in trial NCT04219969?
The interventions under investigation include: Positron Emission Tomography (PROCEDURE), Magnetic Resonance Imaging (DEVICE), Fludeoxyglucose F-18 (DRUG).
Who is sponsoring clinical trial NCT04219969?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04219969's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI